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The role of incongruence between the perceived functioning by patients and clinicians in 
the detection of psychological distress in functional and motor digestive disorders  
Abstract 
Objectives 
Previous research on gastrointestinal and other medical conditions has shown the presence of 
incongruence between self- and clinician-reported functioning and its relation with 
psychopathology. The main objective of this study was to test whether inconsistencies between 
clinician- and self- assessed functionality can be used to detect psychopathology among patients 
diagnosed of motor or functional gastrointestinal disorders. 
Methods 
One hundred and three patients from a gastroenterology inpatient unit were included in this 
study. All patients underwent clinical assessment, including intestinal manometry, Rome III 
criteria for functional gastrointestinal disorders, and psychological and psychiatric evaluation. 
Patients with suspected gastroparesis underwent a gastric emptying test. Definitive diagnoses 
were made at discharge. 
Results 
Patients with higher levels of incongruence differed in various sociodemographic (age, 
educational level, work activity and having children) and psychopathological (all SCL-90-R 
subscales except anxiety and hostility) characteristics. Using general lineal models, incongruence 
was found to be the variable with stronger relations with psychopathology even when controlling 
for diagnosis. Interactions were found between incongruence and diagnosis reflecting a pattern in 
which patients with functional disorders whose subjective evaluation of functioning is not 
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congruent with that of the clinician, have higher levels of psychopathology than patients with 
motor disorders. 
Conclusions 
Incongruence between clinician and self-reported functionality seems to be related to higher 
levels of psychopathology in patients with functional disorders. These findings underscore the 
need for routine psychosocial assessment among these patients. Gastroenterologists could use the 
concept of incongruence and its clinical implications, as a screening tool for psychopathology, 
facilitating consultation-liaison processes. 
 
Keywords: incongruence, clinical performance, subjective functioning, psychological distress, 
functional gastrointestinal disorders, gastrointestinal motility disorders 
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Introduction 
People diagnosed of functional gastrointestinal disorders (FGDs) suffer from a wide range of 
medically unexplained symptoms involving visceral hypersensitivity and impaired 
gastrointestinal motility. These disorders have been widely related to psychosocial factors, such 
as patients’ experiences of illness [1,2]. The integration of gut function with psychosocial 
assessment has been shown to help building an integrated clinical picture of these patients [3–5]. 
Psychosocial interventions such as psychotherapy, hypnotherapy or biofeedback are usually 
related to the effective improvement of functional digestive symptoms [6–8]. 
 
According to biopsychosocial models, multiple stressors can transiently or permanently alter 
physiologic stress responses producing symptoms and also differences in their perception, 
therefore perpetuating them. Nowadays, classic dualism separating mind and body seems to be 
surpassed by more integrative models [9]. Genetic predisposition and early-life stress might 
influence individual vulnerabilities to develop FGDs in adult life. Re-exposure to physiologic or 
psychological stressors may then trigger or exacerbate digestive symptoms [4]. Patients with 
FGDs usually report poor health-related quality of life [10–12], and that has been found to be 
related with psychopathology and functional comorbidities such as chronic fatigue syndrome, 
fibromyalgia or chronic pains [13]. Somatization, the tendency to experience and report multiple 
unexplained somatic symptoms, usually found among these patients [14], seems to play a key 
role in symptom severity and weight loss [15], and has been reported as the most important risk 
factor for impaired quality of life among patients diagnosed with functional dyspepsia [12]. 
Likewise, other psychopathological symptoms like anxiety and depression have been reported to 
worsen functional gastrointestinal symptoms [16]. 
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Patient’s experience with gastrointestinal motor disorders (GMDs) and its relation with distress 
have been less studied from the biopsychosocial perspective. Psychological distress seems to 
worsen the clinical picture among patients with gastroparesis [17]. Another study showed the 
presence of altered manometric observations in patients diagnosed with globus pharingeus [18]. 
In the psychiatric field, some studies have reported gastric dysmotility in patients diagnosed with 
schizophrenia [19] and depression [20,21]. Despite this evidence, no causal relationships or 
common ethiopathological mechanisms are well established. 
 
One of the main problems faced by gastroenterological departments is the lack of resources and 
training for the screening and management of psychosocial factors related to FGDs. For instance, 
according to previous literature, gastroenterologists tend to misattribute FGDs diagnoses among 
patients with psychological distress [22]. Relatedly, our study group has shown in previous 
studies how the perception of functionality is different among clinicians and patients with FGDs, 
but congruent in patients with GMDs [23]. In a similar way, some studies in patients with asthma 
have shown incongruences between self-reported and clinician-reported measures [24]. Likewise 
in an analysis of the contrast between patient and physician assessments of medical comorbidities 
among patients diagnosed with chronic depression, the authors found that discrepancy was 
related to higher levels of depressive symptoms [25]. In a recent study we have found that 
psychopathology is related with incongruence between clinicians’ and self-reported functionality 
assessments among patients diagnosed with gastrointestinal disorders [26]. 
 
The aim of this study is to verify the predictive capacity of the incongruity between the perceived 
functioning by patients and clinicians in the detection of psychological distress in functional and 
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motor digestive disorders. Incongruence thus could be used as a tool of psychological distress 
screening for gastroenterologists facilitating mental health consultation-liaison processes. 
 
Methods 
Participants 
We assessed for eligibility 119 patients with chronic and recurrent gastrointestinal symptoms 
without a clear diagnosis referred to our specialized digestive unit for diagnostic study.  The 
protocol of the study had been approved by the local Ethics Committee and all participants gave 
their written informed consent. 
 
Assessment 
Psychiatric evaluation included a clinical interview conducted by a consultation liaison 
psychiatrist covering the main psychopathological domains according to DSM-IV TR [27] and 
additional administration of psychometric tests (see below). Digestive evaluation included 
intestinal manometry to evaluate small bowel motility and the administration of Rome III criteria, 
Karnofsky Performance Status scale and Body Mass Index in all patients. Patients with suspected 
gastroparesis underwent a scintigraphic gastric emptying test. 
 
Evaluation of small bowel motility by manometry 
Small bowel manometry was performed using a standard technique. After an overnight fast, a 
manometric tube (9012X1106 Special Manometric Catheter; Medtronic, Skovlunde, Denmark) 
was orally introduced into the jejunum under endoscopic guidance. Five manometric ports 
spanned at 10-cm intervals were positioned from the proximal duodenum to the mid jejunum 
under fluoroscopic control. Stationary recording was performed for 3 hours during fasting and 2 
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hours after ingestion of a solid-liquid meal (450 kcal). Patients with recurrent episodes of acute 
intestinal pseudo-obstruction, were evaluated during a period of clinical remission.  Manometric 
diagnosis of abnormal motility was established using the criteria routinely used in our unit that 
are based on previously published data [28]. 
 
Scintigraphic gastric emptying test 
The gastric-emptying rate of the solid component of the meal was measured by an isotopic 
technique. The meal (435 Kcal) consisted of a ham omelette (50g egg and 20 g sliced ham 
cooked with 5 g oil), toast (20 g white bread) with 5g butter and 12 g marmalade, and 200 ml 
fruit juice. The solid component of the meal was labelled by mixing 1 mCi99mTc-sulfur colloid 
with the beaten egg before being cooked to a firm consistency. Abdominal scans in the postictal 
period were obtained with the subject standing in upright position in front of the gamma camera; 
anterior and posterior views were sequentially scanned by asking the subject to turn around in 
front of the camera. Corrections were performed by calculating the geometric mean of the 
sequential anterior and posterior counts. Corrections for isotope decay were also performed. In 
each scan the gastric outline was identified as region of interest and the activity of the isotope in 
the stomach was measured. The total activity of the isotope (100%) was calculated in the first 
determination immediately after patients completed their meal by adding the activity detected 
within the gastric region to that already emptied from the stomach and detected outside the 
gastric region.   Based on the proportion of meal residues remaining in the stomach at 4 h, gastric 
emptying was graded as normal (> 10 % retention) or delayed: mild (11–20 % retention), 
moderate (21–35 % retention) at 4 h; severe, i.e., gastroparesis (<36–50 % retention). 
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Diagnosis of functional gastrointestinal disorders  
All patients were further evaluated by means of structured interviews based on the Rome III 
criteria to determine the presence of criteria of functional gastrointestinal disorders [1]. 
 
Clinician-rated functional impairment 
The Karnofsky Performance Status, KPS [29], was used to assess functional impairment caused 
by the digestive disease. This clinician-administered scale covers a range running from 0 (death) 
to 100 (perfect health). 
 
Psychosocial assessment 
The battery of self-administered questionnaires included: 
- Subjective physical and social functionality was assessed by administering the Short Form 
Health Survey, SF-36 [30]. 
- The Symptom Checklist Revised, SCL-90-R [31] was used as a multidimensional measure 
of psychopathology (including somatization, obsessive-compulsive, interpersonal 
sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation and 
psychoticism). 
 
Determination of incongruence between clinicians’ assessment and patients’ self-reported 
functionality 
Within the patients among which it was possible to collect both the value of the Karnofsky 
performance scale and the SF-36 questionnaire, we defined incongruence as a value above 25 on 
the difference of the former with the physical functioning subscale of the latter. The reasoning 
behind this determination was to detect patients with lower levels of performance that could be 
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explained by the digestive disease. Based on this cut-off, two groups were defined: patients 
among whom there was congruence between their perceived and clinician-assessed functionality, 
and patients among whom the scores were not congruent. As we can see in Figure 1, these values 
allowed us to divide the group of patients among those in which the relationship between self and 
hetero-reported functionality was almost perfect and those in which it was nil keeping a balance 
of similar proportions in both diagnostic groups. According to this cut-off the proportion of 
patients with incongruence was near 40% in both groups (FGD: 39.7%, GMD: 40%, OR=.989, 
95% CI=.394-2.482, p=.982). 
Figure 1. Scatter plot showing the relative congruence between clinician- and self-assessed 
functioning. 
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Data analysis 
T-tests were used to compare continuous socio-demographic characteristics and psychopathology 
measures between congruence groups. Categorical variables were compared between groups 
using chi-squared tests for independence. Finally, general linear models were used to calculate 
the interaction of incongruence and diagnosis in the 9 SCL-90-R psychopathology dimensions. 
Given the high number of variables we applied Bonferroni corrections for multiple comparisons. 
 
Results 
One hundred nineteen patients were enrolled in the study. Eight patients were excluded from the 
study after the psychiatric and digestive assessment as they did not meet criteria for a FGD or a 
GMD, and eight were not able to fill psychometric test and were also excluded. 
 
Results of the Gastrointestinal evaluation 
From the final one hundred and three patients included, twenty-five patients fulfilled criteria of 
intestinal dysmotility and 78 did not. Patients with diagnosis of intestinal dysmotility  presented 
either a) relapsing acute episodes of intestinal pseudo-obstruction (n=18) with radiological 
evidence of intestinal air fluid levels interspersed with relatively symptom-free intervals, or b) 
symptoms compatible with gastroparesis, i.e. chronic (>6 months) postprandial symptoms, such 
as nausea, vomiting, poorly satiation, postprandial fullness,  abdominal discomfort/pain, and 
distension (n=7), with reduced feeding tolerance and inability to maintain normal body weight, 
i.e. Body Mass Index (BMI) below 18.7 in women and 20.1 in men. 
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Figure 2. Flow diagram of the study 
 
 
Assessed for eligibility (n=119) 
Excluded: 
▪ Psychiatric disorder (n=3) 
▪  Anorexia nervosa (n=2) 
▪ Cluster C personality disorder 
(n=1) 
▪ Organic disorder (n=4) 
▪ Pyloric stenosis (n=1) 
▪ Lymphoma (n=1) 
▪ Internal hernia (n=1) 
▪ Angiodysplasia (n=1) 
Patients readmitted (n=1) 
Functional gastrointestinal disorders (n=84) 
 
▪ Irritable Bowel Syndrome (n=43) 
▪ Functional Dyspepsia (n=23) 
▪ Rumination (n=18) 
Gastrointestinal motor disorders (n=27) 
 
▪ Gastroparesis (n=7) 
▪ Pseudo-obstruction (n=20) 
 
 
Included (n=111) 
Data available, n=103 
FGD= 78 (Rumination=17, IBS=39, DF=22) 
GMD=25 (Pseudo-obstruction =18, Gastroparesis=7) 
 
Discordant FGDs (n=31, 39.2%) 
 
Discordant GMDs (n=5, 20%) 
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Among the 78 patients not fulfilling criteria of intestinal dysmotility, 29 presented clinical 
features compatible with gastroparesis; in all of them gastroparesis was ruled out by evaluation of 
gastric motor function. These patients presented early satiation, postprandial fullness, epigastric 
discomfort/pain and all fulfilled Rome III criteria for functional dyspepsia. In 22 of them gastric 
abnormalities of functional dyspepsia were found. The 56 remaining patients without objective 
evidence of gastrointestinal motor disorder (intestinal dysmotility or gastroparesis) 39 presented 
recurrent abdominal pain or discomfort with constipation, diarrhea or both, all fulfilled Rome III 
criteria of Irritable Bowel Syndrome (IBS), and 17 presented persistent or recurrent regurgitation 
of recently ingested food into the mouth that fulfilled Rome III criteria of Rumination Syndrome. 
 
Sociodemographic and psychosocial characteristics 
Sociodemographic characteristics by congruence groups are shown in table 1. Patients among 
whom it was judged that there was a congruence between their perceived and clinician-assessed 
functionality were statistically significantly younger, had higher levels of education, were more 
likely to be professionally active, and less likely to have children Having children and 
professional activity remained statistically active after Bonferroni adjustment (.05/8=.006). No 
statistically significant differences were found in gender distribution, marital status and just a 
tendency was found for higher proportion of psychiatry history among patients with 
incongruence. 
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Table 1. Sociodemographic and psychosocial characteristics of the sample by incongruence 
 
 Incongruence (n=41) No incongruence (n=62) Significance  
 M SD M SD t p 
Age (M±SD) 44.24 11.42 38.63 14.60 2.076, .040 
       
 N  % N % OR, 95% CI p 
       
Sex (% females) 35 85.4 47 75.8 1.862, .656-5.823 .238 
       
Education (at least higher or vocational) 11 26.8 29 46.8 2.397, 1.022-5.619 .042 
       
Professionally active* 22 53.7 50 80.6 3.598, 1.493-8.672 .003 
       
Marital status (married or stable couple) 
** 
28 68.3 35 56.7 .602, 263-1.377 .227 
       
Children (yes) 32 78.0 29 46.8 4.046, 1.658-9.873 .002 
       
Psychiatric history (yes) 25 61.0 26 41.9 2.163, .967-4.840 .059 
FGD: functional gastrointestinal disorders (functional dyspepsia, rumination and irritable bowel syndrome). 
GMD: gastrointestinal motility disorders (chronic intestinal pseudo-obstruction, gastroparesis and inability).  
These categories were collapsed because of low n: 
*Any work activity or studies 
**The rest includes: single, divorced, and widow patients 
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Psychopathology 
Differences in psychopathology variables by diagnostic and incongruence groups are shown in 
figure 3. When comparing scores between diagnostic groups, no SCL-90-R subscale showed 
statistically significant differences. In the case of incongruence, all subscales except anxiety 
(t=1.850, p=.067) and hostility (t=1.482, p=.141) showed statistically significant differences, with 
higher values for patients with incongruent scores. After applying Bonferroni corrections for 
multiple comparisons (.05/9=.0055) only phobic anxiety lost statistical significance. Within 
diagnostic groups, no statistically significant difference was found between GMD incongruence 
patients groups, while all the SCL-90-R scores were found to be statistically different between 
FGD incongruence patient groups. 
 
Table 2 shows the results of the general linear models using diagnosis and congruence as factors 
(independent variables) and psychopathology dimensions as dependent variables. No variable 
showed between subjects’ effects regarding diagnosis and incongruence retained statistical 
significance just in the case of somatization and depression. Interaction between both variables 
was statistically significant in the case of interpersonal sensitivity, phobic anxiety, psychoticism 
and the overall generalized form (MANOVA). 
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Table 2. General linear models of SCL-90 scores 
 
Independent 
variable 
Incongruence Diagnosis 
(FGD. 
GMD) 
Interaction 
 F p ηp2 F p ηp2 F p ηp2 
          
Somatisation 8.274 .005 .078 .582 .447 .006 .114 .736 .001 
Obsessive-
compulsive 
3.685 .058 .036 .025 .874 .000 1.135 .289 .011 
Interpersonal 
sensitivity 
1.531 .219 .015 .184 .669 .002 7.642 .007 .072 
Anxiety  1.484 .226 .015 .047 .828 .000 .498 .482 .005 
Depression 4.736 .032 .046 .324 .571 .003 1.546 .217 .016 
Hostility .617 .434 .006 .077 .782 .001 .890 .348 .009 
Phobic anxiety  .758 .386 .008 2.591 .111 .026 8.216 .005 .077 
Psychoticism 2.270 .135 .023 .099 .753 .001 4.184 .043 .041 
Paranoid ideation 2.477 .119 .025 .256 .614 .003 3.206 .076 .032 
MANOVA 
(Phillai’s trace) 
1.509 .157 .131 1.178 .319 .105 2.035 .044 .169 
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Figure 3. SCL-90 mean scores by diagnosis and congruence groups 
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Discussion 
Our study shows how the incongruence between clinician-assessed and patient self-reported 
functionality could be a straightforward tool for the screening of psychological distress at 
gastroenterology units.  
 
Patients with incongruence were older, were more likely to be professionally inactive, to have 
lower levels of education and were more likely to have children. Patients whose views of 
functionality were incongruent with those of the clinicians were nearly six years on average older 
than those who did not. The presence of incongruence may hinder the integrated understanding of 
the whole clinical picture by gastroenterologists lengthening the diagnosis process and hampering 
the implementation of an adequate treatment. The age of patients might be also be related to the 
likelihood of having children. Furthermore, the more complicated clinical picture of patients with 
views of their functioning incongruent with those of the clinician, might be related with lower 
social functioning capacities. 
 
In our study, incongruence is related with absolute differences in all psychopathological domains 
although statistical significance and control for multiple comparisons excluded anxiety, hostility 
and phobic anxiety. In turn, we did not obtain any statistical significance when comparing 
psychopathology dimensions between diagnosis groups. Somatization and depression showed 
between subjects’ statistically significant effects for incongruence when also controlling for 
diagnosis. These two variables are those with a greater difference between congruence patient 
groups when even controlling for diagnosis. Interactions between incongruence and diagnosis 
were found for interpersonal sensitivity, phobic anxiety and psychoticism. In these three cases 
GMD patients with congruent assessments showed slightly higher (but not statistically significant 
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when compared using t-tests) levels of psychopathology than their peers. In contrast, the situation 
among FGDs showed a dramatic predominance of psychopathology among patients with 
incongruence when compared with their congruent peers. 
 
Somatization has been widely found among patients diagnosed with IBS [32] as it seems to 
increase postprandial symptoms among them [33]. On the one hand, the relationship between 
higher levels of psychopathology and the incongruence of clinicians and patient’s perception in 
FGDs, could be related to somatosensory amplification [1,2,34], a psychobiological mechanism 
which amplifies body symptoms perception and that it is maybe not well taken into account by 
gastroenterologists [35]. In our study, somatization measured by the SCL-90-R does not allow us 
to deepen in the origin of somatization. Some previous studies have shown how somatosensory 
amplification is related to FGDs [34,36] and it has been found to be related with increased report 
of drugs’ side effects [37].  On the other hand, as we showed in an earlier publication [26] 
increased levels of somatization as measured with the SCL-90-R among patients with GMDs, 
could be explained by severe medical conditions. Among these patients, incongruence could be 
related to the way that patients with severe medical comorbidities express their discomfort. Our 
finding related to the higher levels of depressive symptomatology among congruent patients 
agrees with the results found by Schrader [25]. Depressive symptoms have classically been 
related to negative perceptions and distortions [38]. In this regard depressive symptomatology 
might be related to uncontrollability and unpredictability cognitions that have been related with 
decreased levels of physical health [39].  
 
Obsessive-compulsive symptoms were also strongly related to incongruence just in patients with 
FGDs. One possible explanation is that patients with obsessive symptoms have higher levels of 
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psychological inflexibility. Psychological flexibility has been defined as a present-mindedness 
approach to situation-response, accepting and adapting own behaviors based on personally held 
values [40]. In contrast, psychological inflexibility is marked by disabling avoidance and 
ruminative thoughts, which interfere with personal self-direction [41]. Previous research has 
evidenced how psychological factors such as inflexibility, hypervigilance, attentional bias and 
pain catastrophizing increase abdominal pain sensations and worsen the prognosis of these 
patients [42]. Obsessive-compulsive symptoms may increase the digestive pain experience via 
psychological mechanisms as hypervigilance, causing the incongruence between clinician-
assessed and subjective measures [43]. Further research showed how IBS was highly present 
(35,1%) in a sample of patients diagnosed with obsessive-compulsive disorder (OCD) [44]. 
Authors attribute this relation to the neurobiological common pathways via 5-HT receptors in 
both diseases and in other FGDs. In addition, some brain treatments for resistant OCD seem to 
improve IBS symptoms [45]. Some studies in fMRI show how the anterior cingulate cortex 
(ACC) is significantly more active in patients with OCD. It is known that the ACC is involved in 
visceromotor control and nociception [46]. 
 
All these results taken together highlight the importance of taking into consideration the 
differences that occur when it is self-reported or clinician-rated [47]. Relatedly, subjective health 
assessment by patients might give gastroenterologists additional information about their overall 
clinical picture [48]. Incongruences between clinician’s and patients perceptions of quality of life 
have been found in medical conditions such as multiple sclerosis [49], asthma [24], or hip 
arthroplasty [50], and seems to be related with different clinical outcomes such as macular 
degeneration [51,52]. A previous study showed how incongruence was related to depression [25], 
as it happens in our study, especially among patients diagnosed with FGDs. For that reason we 
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uphold that incongruence can be a simple screening tool for gastroenterological use aiming to 
detect patients who need further mental health support. In this sense, previous literature shows 
evidence for the use of psychological [7,53,54] and psychotropic drugs [55,56].  
 
Limitations of our study should also be discussed. On the one hand, our study was carried in a 
highly-specialized tertiary gastrointestinal unit. Further studies should be carried to be able to 
settle whether incongruence is related to psychopathology in patients with FGDs treated at 
different healthcare levels. On the other hand, we haven’t used specific assessment tools for each 
digestive diagnostic included in this study. However, we used universal psychometric tests that 
allowed us to compare psychological distress in different diagnostic groups. In addition, cross-
sectional evaluation doesn’t allow us to deepen in the causes of clinical incongruence, preventing 
us to delve into the reasons for the higher age and the possible differences in the evolution of the 
disorder. These limitations may hamper the generalizability of our results to other clinical 
settings such as primary or secondary care. 
 
In spite of the evidence of increased psychological distress, psychosocial assessment seems to be 
a gap in the diagnostic process of digestive patients. Furthermore, digestive patients might suffer 
from subclinical psychiatric syndromes, not easily diagnosable by common clinical interviews 
[2]. Some authors have tried to improve this situation designing diagnostic tools able to detect 
subsyndromal symptoms, psychosomatic reactions [57,58] and specific psychopathology 
symptoms [59] in digestive patients, although its use is still not generalized in this population.  
 
In this study we have seen how psychopathology seems to be related to the different perceptions 
of illness that clinicians and patients have. Therefore, incongruence of patient and clinician-
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provided functionality can be used as a simple screening tool for psychopathology, especially 
among patients with FGDs, facilitating the mental health consultation-liaison processes. 
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